Breaking News

Adragos Pharma Takes Over Clinigen’s Development Unit, Lamda Laboratories

Acquisition strengthens Adragos' end-to-end integrated pharmaceutical product development service offering.

Adragos Pharma GmbH, a contract development and manufacturing organization (CDMO), acquired Lamda Laboratories S.A. in Athens. With the transaction, Adragos Pharma will operate three sites in Europe and five globally. The acquisition of Lamda Laboratories significantly expands Adragos’ pharmaceutical product development, regulatory affairs, and supply chain management services for its global pharmaceutical customers. Lamda will continue to provide services for Clinigen. The Athens...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters